Biosynthetic gene clusters (BGCs) are organized groups of genes involved in the production of specialized metabolites. Typically, one BGC is responsible for the production of one or several similar compounds with bioactivities that usually only vary in terms of strength and/or specificity. Here we show that the previously described ferroverdins and bagremycins, which are families of metabolites with different bioactivities, are produced from the same BGC, whereby the fate of the biosynthetic pathway depends on iron availability. Under conditions of iron depletion, the monomeric bagremycins are formed, which are amino-aromatic antibiotics resulting from the condensation of 3-amino-4-hydroxybenzoic acid with p-vinylphenol.
Bagremycin Antibiotics and Ferroverdin iron-chelators are synthetized by the Same Gene Cluster

Introduction
Specialized metabolites are natural products that play essential roles by helping the producing strain to cope with various stresses, used as weapons to outcompete neighboring commensals, or required at particular physiological or developmental stages [1, 2] . Besides their role in improving the fitness of microorganisms in their habitat, amongst others, molecules emanating from the so-called secondary metabolism are of foremost therapeutic and agroindustrial importance [3, 4] . These bioactive compounds are produced by a machinery encoded by a group of genes -a Biosynthetic Gene Cluster (BGC) -that, next to biosynthetic genes, typically includes genes for expression control, self-resistance and export [4] [5] [6] .
Genome sequencing of secondary metabolite-producing microorganisms has revealed the enormous potential to increase the known chemical space [5] , with the promise of new leads in human therapies or for sustainable agriculture. One of the drivers of the renewed interest in natural products (NPs) was the discovery of so-called cryptic BGCs that are silent under routine laboratory conditions and may therefore specify molecules that had so far been missed during pharmaceutical screening [7] [8] [9] . An approach that is rapidly gaining momentum is to express cryptic BGCs in a heterologous chassis strain or superhost, and change promoter elements within the BGC by those that are expected to result in high expression under laboratory conditions. However, there are several problems associated with this approach. Firstly, it is yet not very amenable towards high-throughput strategies, and it is hard to establish the promise of a certain BGC based on the DNA sequence alone [10] . Secondly, examples are accumulating of NPs that are produced from multiple BGCs, or by strains in coculture [11, 12] . Alternatively, a single BGC may also be responsible for the production of many (up to over 100) structurally related molecules that differ in terms of their activity [13] [14] [15] , or BGCs can be associated as "superclusters" to produce one or more similar molecules [16, 17] . Thus, to optimally exploit the chemical space of NPs, we need to understand the connection between the genomic and chemical diversity of their biosynthetic pathways.
Here we provide an example that further illustrates the complexity to estimate the metabolome profile and the industrial potential of a microorganism based on the genomic information alone. Our work revealed that the ferrous compounds called ferroverdins ( Figure   1 , structures 1 to 3 [18] [19] [20] ), which are inhibitors of cholesterylester transfer protein (CETP) and thus molecules potentially able to reduce the risk of atherosclerosis [21] , and the antibiotics bagremycins ( Figure 1 , structures 4 to 9 [22] [23] [24] ), are synthesized from the same BGC. These molecules not only have completely different biological functions, but their biosynthesis also requires different environmental triggers. These findings challenge the concept suggesting that one BGC is associated with the production of similar compounds in terms of building blocks, structure, bioactivity, and condition for production. including their molecular formula. The monomer specific to ferroverdin B (hydroxy-p-vinylphenyl-3,4-NHBA), and the monomer specific to ferroverdin C (and carboxy-p-vinylphenyl-3,4-NHBA) are shaded in grey.
Results
Streptomyces lunaelactis produces ferroverdins and bagremycins
Strains of Streptomyces lunaelactis, including the type-strain MM109 T , were previously isolated from cave moonmilk deposits [25] [26] [27] . The strain MM109 T produces a green pigment that was attributed to the biosynthesis of ferroverdin A [25] , a homotrimer of p-vinylphenyl-3-nitroso-4-hydroxybenzoate (p-vinylphenyl-3,4-NHBA) complexed with one ferrous ion [18, 19] . To assess the metabolomic response of S. lunaelactis including conditions in which ferroverdin A is produced, strain MM109 T was grown under different culture conditions. For this, disc diffusion assays were performed, in the presence of a range of different metals. This revealed that only the addition of FeCl3 triggered production of the green pigmented ferroverdin A by S. lunaelactis MM109 T (Figure 2A) . Production of ferroverdin A (structure 1
in Figure 1 , and Figure 2C ) was triggered at a FeCl3 concentration as low as 0.01 mM ( Figure   2B ). UPLC-MS/MS analysis of extracts of strain MM109 T identified an ion peak of m/z 876.11 Figure 3BC , and structures 4, to 9 in Figure 1 ). Bagremycins are aminoaromatic antibiotics resulting from the condensation of 3-amino-4-hydroxybenzoic acid (3,4-AHBA) with p-vinylphenol [22] [23] [24] . Note the antibacterial activity associated with pure bagremycin A (peak #4), and bagremycin B (peak #5). C.
Extracted ion chromatograms (EIC) of the six known bagremycins detected in the full extract of S. lunaelactis
MM109
T is the type strain of S. lunaelactis, but many other strains belonging to the species S. revealed that all strains except strain MM91 were able to produce at least one bagremycin and one ferroverdin ( Figure 4B ). These data suggest that the production of bagremycins, like the production of ferroverdins, is a common feature of moonmilk-dwelling strains belonging to the species S. lunaelactis. Identification of a BGC similar to fev and bag clusters in S. lunaelactis MM109 T In order to identify the genes involved in the production of bagremycins (bag) and/or ferroverdins (fev) in S. lunaelactis MM109 T , the genome of this strain [28] was mined using the antiSMASH v4.0 software [29] . 37 BGCs were identified, namely 36 BGCs on the linear chromosome and one additional BGC on the linear plasmid pSLUN1 (Supplementary Figure   S1 ). BGC #12 (from SLUN_21350 to SLUN_21430 [28] ) shares strong gene synteny with the bagremycin BGC from Streptomyces sp. Tü 4128 [30, 31] , with high similarity between the predicted gene products (coverage 99%, average identity 86.2%, average similarity 91.9%) ( Figure 5A , Table 1) . Surprisingly, BGC #12 shares similarly strong gene synteny and high similarity between the gene products with the fev cluster (GenBank: AB689797) of the ferroverdin producer Streptomyces sp. WK-5344 (coverage 99%, average identity 85.8%, average similarity 91.3%) ( Figure 5A , Table 1 ). The level of identity between the proposed fev cluster of Streptomyces sp. WK-5344 and the bag cluster of Streptomyces sp. Tü 4128 are even greater with on average 96% aa identity and 97.4% similarity ( Figure 5A , Table 1 ). The exceptionally high levels of average amino acid identity suggest that the biosynthesis of bagremycins and ferroverdins might be mediated by the same BGC. This was further supported by comparative analysis of the BGCs involved in the production of other amino/nitrosoaromatic metabolites i.e., the nsp gene cluster for biosynthesis of 4-hydroxy-3-nitrosobenzamide in Streptomyces murayamaensis [32] , and the gri gene cluster involved in grixazone production is Streptomyces griseus [33] . The nsp and gri clusters share seven homologous genes with those identified in the bag/fev cluster ( Figure 5A , Table 1 unlikely that bagremycins and ferroverdins should be specified by two different BGCs. A plausible pathway for the synthesis of both bagremycins and ferroverdin A from the fev/bag cluster is proposed in the Discussion section (see also Figure 8 ). 
Inactivation and/or duplication of fevR affects both ferroverdin and bagremycin production
Of the S. lunaelactis strains that were collected from the moonmilk samples, strain S.
lunaelactis MM91, which does possess a complete fev/bag cluster (GenBank: MG708299), failed to produce the ferroverdin-associated green pigmentation when grown in iron-containing media ( Figure 6A and 6B). MM91 also showed reduced production of all bagremycins except bagremycin B ( Figure 6C ).
The phenotype of S. lunaelactis MM91 allowed a forward genetic approach to assess if the fev cluster is indeed responsible for production of both bagremycins and ferroverdins. Genome sequencing and SNP analysis of S. lunaelactis strain MM91 revealed a deletion at nucleotide position +337 of SLUN_21380 (bagI or fevR), which encodes the likely pathway-specific activator of the BGC ( Figure 6D ). This deletion results in a frameshift leading to a premature stop codon, 17 amino acids downstream of the deletion, and thus in a truncated (and likely inactive) protein.
To ascertain that FevR/BagI is required for both ferroverdin and bagremycin production, the These data suggest that indeed FevR/BagI is the pathway-specific activator for the BGC, and this was further supported by the observation that introduction of an additional copy of fevR/bagI into S. lunaelactis MM109 T resulted in increased production of both ferroverdins and bagremycins ( Figure 6E ). 
Iron is required for production of
MS/MS spectra of p-vinylphenyl-3-nitroso-4-
hydroxybenzoate with the proposed fragmentation mechanism.
Discussion
In this work we provided genomic, genetic and metabolomic evidences that a single BGC lunaelactis: bagremycins display antibacterial, antifungal and anti-proliferative activities presumably in order to inhibit growth of neighboring competing bacteria and fungi and/or to control self-proliferation, while p-vinylphenyl-3,4-NHBA production would be only required when iron excess constitutes a main threat in order to limit iron-mediated oxidative damages.
The change of the amino-in a nitroso-group in bagremycin allows complexation with iron, which strongly suggests an evolutionary driver for this chemical diversification.
We propose a possible biosynthetic pathway for both bagremycins and ferroverdins ( Figure 8 ) based on the deduced function of the different components of the bag/fev clusters, and the current knowledge on the biosynthetic pathway of bagremycins [22, 30, 31, 34] . In addition, as biosynthesis is known for two other types of amino/nitroso-aromatic compounds, namely grixazones (gri genes) and 4-hydroxy-3-nitrosobenzamide (nsp genes), the information available for these BGCs is useful to predict steps shared by the studied pathways.
As demonstrated previously, bagremycin A is derived from precursors p-vinylphenol and 3-amino-4-hydroxybenzoic acid (3,4-AHBA) [22] . The p-vinylphenol is generated in two steps from L-tyrosine which is first deaminated by FevV/BagA in trans-coumaric acid, the latter being decarboxylated in p-vinylphenol by FevK (BagM) and FevL (BagN). Indeed, FevK and FevL form a UbiX-UbiD system where UbiD is a decarboxylase that requires prenylated FMN as cofactor, which is provided by the flavin prenyltransferase UbiX [35] . Regarding the second precursor 3,4-AHBA, it was demonstrated that it is formed from dihydroxyacetone phosphate (DHAP) and L-aspartic-4-semialdehyde (ASA) through two reactions catalyzed by BagB (FevI) and BagC (FevH) [30] . Condensation of the p-vinylphenol and the 3,4-AHBA to form bagremycin A would be mediated by FevW which shows high similarities with proteins of the phenylacetate-CoA ligase family, which catalyze the condensation of two molecules by their carboxillic and alcohol moieties through adenylation.
Regarding the synthesis of p-vinylphenyl-3,4-NHBA, the monomer of ferroverdin A
and major monomer of other ferroverdins, we propose that it would directly result from precursors p-vinylphenol and 4-hydroxy-3-nitrosobenzoic acid (4,3-HNBA) (Figure 7 ). 4.3-HNBA would be directly generated via the nitrosation of 3,4-AHBA and would be mediated by the copper-containing oxidase FevF (with FevE as chaperone). FevF is a copper-containing oxidase which is orthologous to NspF and GriF, while FevE is a copper chaperone orthologous to NspE and GriE (Table 1) . NspE bring two coppers to NspF, which converts 3-amino-4-hydroxybenzamide into 4-hydroxy-3-nitrosobenzamide in Streptomyces murayamaensis [32, 36] . Likewise, GriE donates two coppers to GriF, which converts o-aminophenol into o-quinone imine in Streptomyces griseus [37] . Since these FevF/FevE orthologous proteins mediate the oxidation of 3.4-AHBA-like substrates to generate quinone imine moieties which would be consecutively nitrosilated, we suggest that these enzymes are both able to mediate the Finally, next to the role of iron as vital element for growth [38, 39] , morphogenesis and metabolite production [12, 39, 40] , our work reveals an unprecedented complexity of natural product biosynthetic pathways where this element is also an environmental trigger able to change the pattern of natural compounds produced by a single BGC. By challenging the concept that one BGC should produce a single family of molecules, our results also highlight the difficulty to estimate the metabolic potential of an organism based on the genomic information alone.
Materials and methods
Strains and culture conditions
All strains used in this study are listed in Table 1 . Escherichia coli strains were grown in liquid LB or on solid LB medium agar plates and incubated at 37°C. Media used for solid Streptomyces cultures were R2YE, SFM, and ISP7 agar plates and incubated at 28°C. When required, antibiotics thiostreptone, kanamycin, nalidixic acid, and ampicillin were added in the culture media. The type strain S. lunaelactis MM109 T [25] and other S. lunaelactis strains were isolated from the cave 'Grotte des Collemboles' Collemboles' (Comblain-au-Pont, Belgium) [25] [26] [27] . Media composition and methods associated with Streptomyces species were all performed as described in [41] .
Creation of fevR knock-out and overexpression mutants in S. lunaelactis MM109
In order to assess the effect of fevR/bagI on both bagremycin and ferroverdin production we first generated a S. lunaelactis MM109 knock-out strain in which orf SLUN21380 was interrupted by a single cross-over with a thiostreptone resistance cassette. A 791 bp internal fragment (starting at position +116 nt and lacking the 81 last nt of SLUN21380) was amplified by PCR using primers FevR+118f_XbaI (TCTCTAGACGAACCAGGTGGTCAGCC) and 
Compound extraction and analysis by High Pressure Liquid Chromatography (HPLC)
Compound extraction and HPLC analysis were mainly performed as described previously [26] .
All S. lunaelactis strains were cultured for 10 days on different solid media on Petri dishes (90 mm, 25 ml of medium) and incubated at 28 C°. The solid cultures were cut into small pieces antibacterial activities against Staphylococcus aureus (ATCC25923) by disk diffusion assay as describe previously [26] .
Compound identification by Ultra-Performance Liquid Chromatography-Tandem Mass
Spectrometry (UPLC-MS/MS).
UV-VIS spectra absorbance were obtained by analytical HPLC RP-C18 analyses. HRESIMS data were acquired on a Q Exactive Plus hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Briefly, compounds were separated by reversephase chromatography using Ultra Performance Liquid chromatography (UPLC IClass, Waters) using a Nucleodur C18ec column (2.0 mm × 150 mm, 5 µm particle size, MachereyNagel). Elution was achieved by increasing the acetonitrile/water (milliQ filtrated on 0. Each compounds was identified by its exact mass, isotope pattern, observation of the MS/MS spectra obtained on the molecular ion fragmentation, and the UV-VIS absorbance spectra. For each molecule a fragmentation pathway was proposed (see Supplementary Figure S3 ).
Bioinformatics
The complete genome sequence of S. lunaelactis strains was obtained by Illumina HiSeq, and
MiSeq (Illumina, CA, USA) technologies as described previously [28] . The two sequencing techniques were performed at the GIGA-Research Center (Liège University, Belgium), and at the Luxembourg Institute of Science and Technology (Belvaux, Luxembourg), respectively.
Genomes were assembled as described previously and using the complete genome sequence of the type strain S. lunaelactis MM109 T as template [29] .
Phylogeny analyses were performed with sequences of homolog proteins from the fev (S. 
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